AZ settles $355m fraud case

October 29, 2003

AstraZeneca has settled the case relating to fraudulent sales of its prostate cancer drug Zoladex, and will pay a total …

Department of Health takes a dose of its own medicine

October 29, 2003

The Department of Health is to open itself up to the same adical transformationit is overseeing in the NHS by …

Final battle for future of US healthcare draws near

October 29, 2003

The future of the US healthcare system and how patients pay for their medicines will be decided in the coming …

Pfizer cool on Prilosec OTC launch

October 29, 2003

Pfizer has criticised the US approval of an over-the-counter formulation of AstraZeneca's heartburn drug Prilosec, saying it will only serve …

Biotech consolidation picks up with $6.4bn deal

October 29, 2003

The recent run of biotech consolidation has stepped up a gear as Biogen and Idec have agreed a $6.4 billion …

Foundation status reform not most important, say trusts

October 29, 2003

The Government's plans for foundations hospitals will have much less impact on the NHS than other reforms of the health …

Novartis buys Pfizer incontinence drug

October 29, 2003

Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …

Look closer – The importance of local opinion leaders

October 29, 2003
Sales and Marketing key opinion leaders

There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …

Roche survey shows cancer postcode prescribing continues

October 29, 2003

A new UK-wide survey by Roche has shown a third of breast cancer patients who could benefit from its NICE-approved …

Limited lifting of NICE ‘ban’ on Tamiflu

October 29, 2003
Sales and Marketing

Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …

The new GP contract : incentives for pharma too

October 29, 2003
GP contract, NHS, healthcare

As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …

Betaferon and Avonex in head-to-head MS trial

October 29, 2003
Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …

Aventis awards ClinPhone preferred supplier status

October 29, 2003
Research and Development

Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …

The Gateway to Local Adoption Series

Latest content